Product Information

CARVEDILOL ER 40 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $6.4442 per EA under NDC 57664066583. Its NADAC has been published 444 times since Feb 21, 2018.

FDA first approved this application on Oct 25, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CARVEDILOL ER 40 MG CAPSULE

Carvedilol Phosphate
$6.4442per EA

Strength

40 mg/1

NDC

57664066583

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CARVEDILOL PHOSPHATE

Approval Type

Generic (ANDA)

FDA Application

ANDA090132

FDA Approved

10/25/2017

TE Code

AB

On Market Since

11/8/2017

Pharmacological Classes

Adrenergic alpha-Antagonists
Adrenergic beta1-Antagonists
Adrenergic beta2-Antagonists
alpha-Adrenergic Blocker
beta-Adrenergic Blocker

Price Statistics

The NADAC for CARVEDILOL ER 40 MG CAPSULE has been published 444 times since Feb 21, 2018, and over the history we have for it it has declined 2.3%. The table below summarizes its recorded NADAC range and movement.

Current price$6.4442 per EA
All-time high$7.0845 (Jan 16, 2019)
All-time low$4.0723 (Nov 20, 2024)
52-week high$6.6829
52-week low$5.5853
Median price$5.8605
Average price$5.8571
Largest weekly change-29.1% (Nov 20, 2024)
Weeks tracked444
Tracking sinceFeb 21, 2018

Price History

1W

-3.6%

1M

-3.6%

3M

+4.1%

6M

+13.1%

1Y

+13.6%

3Y

+18.4%

5Y

+11.7%

All

-2.3%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of CARVEDILOL ER 40 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL ER 40 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $6.4442 per EA (NDC 57664066583), effective Aug 19, 2026.

How has the price of CARVEDILOL ER 40 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for CARVEDILOL ER 40 MG CAPSULE has declined 2.3%. It has been tracked across 444 weekly CMS publications since Feb 21, 2018.

What are the highest and lowest recorded NADAC prices for CARVEDILOL ER 40 MG CAPSULE?

Since Feb 21, 2018, the NADAC for CARVEDILOL ER 40 MG CAPSULE has ranged from a low of $4.0723 (Nov 20, 2024) to a high of $7.0845 (Jan 16, 2019), with a median of $5.8605 per EA.

Are there cheaper alternatives to CARVEDILOL ER 40 MG CAPSULE?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CARVEDILOL ER 40 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures CARVEDILOL ER 40 MG CAPSULE?

CARVEDILOL ER 40 MG CAPSULE (NDC 57664066583) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.